South Korea Nanomedicine Market Size, Share, and COVID-19 Impact Analysis, By Application (Drug Delivery and Therapeutics), By Indication (Clinical Oncology and Infectious Diseases), By Molecule Type (Nanoparticles, Nanotubes, Nanodevices, and Nanoshells), and South Korea Nanomedicine Market Insights, Industry Trend, Forecasts to 2035

  South Korea Nanomedicine Market Insights Forecasts to 2035

• The South Korea Nanomedicine Market Size Was Estimated at USD 3,845.8 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 11.68% from 2025 to 2035
• The South Korea Nanomedicine Market Size is Expected to Reach USD 12,968.8 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, The South Korea Nanomedicine Market Size is anticipated to Reach USD 12,968.8 Million by 2035, Growing at a CAGR of 11.68% from 2025 to 2035. The increasing use of drug delivery techniques based on nanotechnology and the widespread ineffectiveness of traditional treatments offer new opportunities for the nanomedicine sector to expand.

Market Overview

The industry devoted to using nanotechnology to enhance medical diagnosis, treatment, and prevention is known as the nanomedicine market. It includes a variety of goods and technologies that function at the nanoscale (one billionth of a meter), such as nanoparticles, nanorobots, and nanoscale diagnostic instruments. Through the use of improved imaging tools, tailored medicine, and more targeted drug administration, this profession seeks to transform healthcare. By increasing drug solubility and bioavailability, nanoparticles can increase the effectiveness of pharmaceuticals. Additionally, they can shield medications from deterioration within the body, guaranteeing that they arrive at their destination in an active state. Early and more precise illness detection is made possible by nanomaterials, which improve the sensitivity and specificity of diagnostic instruments. By acting as contrast agents in imaging procedures, nanoparticles can enhance the visibility of cancers and other anomalies. In order to promote innovation and hasten the commercialization of nanomedicine solutions, governments support partnerships between public research institutes and private businesses.

Report Coverage

This research report categorizes the market for South Korea nanomedicine market based on various segments and regions forecasts revenue growth, and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea nanomedicine market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea nanomedicine market.

Driving Factors

The increasing demand for targeted drug delivery systems that enhance treatment efficacy and reduce side effects. Rising prevalence of chronic diseases, especially cancer and infectious diseases, fuels the need for advanced therapies. Technological advancements in nanocarriers, nanoparticles, and nanodevices are improving precision medicine capabilities.

Restraining Factors

High development and production costs, including expenses for research, clinical trials, and specialized manufacturing, limit accessibility and affordability. Stringent regulatory requirements and lengthy approval processes can delay product launches. Safety concerns, such as potential toxicity and long-term effects of nanoparticles, add to the complexity.

Market Segmentation

The South Korea nanomedicine market share is classified into application, indication, and molecule type.

• The drug delivery segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea nanomedicine market is segmented by application into drug delivery and therapeutics. Among these, the drug delivery segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. Its ability to enhance targeted therapy, reduce side effects, and improve bioavailability. Growing demand for precision medicine, advancements in nanocarrier technologies, and increased R&D investments.

• The clinical oncology segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea nanomedicine market is segmented by indication into clinical oncology and infectious diseases. Among these, the clinical oncology segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. The rising cancer prevalence and demand for targeted, less toxic treatments. Nanomedicine enables precise drug delivery to tumors, improving efficacy and minimizing side effects. Increased R&D funding and adoption of personalized medicine further support its strong growth trajectory.

• The nanoparticles segment dominated a share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea nanomedicine market is segmented by molecule type into nanoparticles, nanotubes, nanodevices, and nanoshells. Among these, the nanoparticles segment dominated a share in 2024 and is expected to grow at a significant CAGR during the forecast period. Their versatility in drug delivery, imaging, and diagnostics. Their ability to improve solubility, stability, and targeted delivery of therapeutics makes them highly effective. Growing adoption in oncology and chronic disease treatment continues to drive strong market growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea nanomedicine market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• AnyGen
• BioSpectrum
• Celltrion
• GeneMatrix
• Green Cross (GC Biopharma)
• Hanmi Pharmaceutical
• LG Chem
• MEPSGEN
• NanoEntek Inc.
• Samsung Biologics
• Promedius Inc.
• SK Bioscience
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea nanomedicine market based on the below-mentioned segments:

South Korea Nanomedicine Market, By Application

• Drug Delivery
• Therapeutics

South Korea Nanomedicine Market, By Indication

• Clinical Oncology
• Infectious Diseases

South Korea Nanomedicine Market, By Molecule Type

• Nanoparticles
• Nanotubes
• Nanodevices
• Nanoshells